Shkreli, who was arrested by the Federal Bureau of Investigation (FBI) after the SEC’s charge, has been released on a $5m bond.
Advertisement
Pitino denies making obscene gesture at United Kingdom fan
UK’s first six points came off second-chance opportunities, this against a U of L team ranked No. 2 nationally in rebound margin. Kentucky’s second-leading scorer, Isaiah Briscoe , sat out after hurting his ankle during pregame warmups.
Martin Shkreli, the poster boy for large prescription drug price increases, has stepped down as chief executive of Turing Pharmaceuticals, the company said on Friday, following his arrest for securities fraud earlier this week. The alleged scheme involved help from the company’s lawyer, Evan L. Greebel, who was also arrested and charged on Thursday with one count of wire fraud conspiracy.
Israel police: Soldier stabbed in Jerusalem, attacker caught
An ultra Orthodox Jew flashes victory signs at the scene of an alleged stabbing attack in Jerusalem Saturday, Dec. 26, 2015. The military said the pair of attackers stabbed the soldier at a gas station near the Hawara crossing, south of Nablus.
Ron Tilles, the chairman of the board of the privately held company, will serve as interim chief executive until a formal replacement is named, according to a Turing news release.
Boxing Day stats: Best facts and figures from the Premier League
Last season the two clubs played out a 2-2 draw at Anfield, with Leicester coming from 2-0 down to claim a share of the spoils. At White Hart Lane Harry Kane scored twice as Tottenham beat Norwich 3-0.
Mr Tilles has worked at numerous private equity and venture capital firms in the pharmaceutical and medical device industries over the past two decades.
Shkreli became known as the “bad boy” of pharmaceuticals for defiantly raising the price of the life-saving drug Daraprim from $13.50 to $750. Turing ended up reducing what it charges hospitals for Daraprim by as much as 50 percent.
Shkreli’s Turing Pharmaceuticals caused global outrage in September after it hiked the price of a Daraprim, a 70-year-old drug used by cancer and Aids patients, by 5,000% overnight.
Shkreli has been the focus of widespread criticism in the media, which dubbed him “the most hated man in America”, as well as by politicians.
Andrew J Ceresney, director of the Securities and Exchange Commission, said that Mr Shkreli committed “nearly every aspect of hedge-fund investments and in connection with his stewardship of a public company”.
The news – unrelated to his actions at Turing – delighted patients, advocacy groups and others who found his price-gouging despicable.
Last month, Shkreli acquired a majority stake in publicly traded drugmaker KaloBios Pharmaceuticals Inc. and became CEO of that company too.
Advertisement
Bloomberg and Reuters reported that Shkreli was arrested Thursday at his home in NY. “Thanks for the support”.
